Amphastar Pharmaceuticals (AMPH) Buildings (2013 - 2015)

Amphastar Pharmaceuticals' Buildings history runs 3 years deep, the most recent figure standing at $67.8 million for Q2 2015.

• In Q2 2015, Buildings rose 5.71% year-over-year to $67.8 million; the TTM figure through Jun 2015 stood at $67.8 million (up 5.71% YoY), while the FY2014 annual figure was $67.8 million, up 15.05% from the prior year.
• Buildings was $67.8 million for Q2 2015 at Amphastar Pharmaceuticals, up from $67.4 million in the prior quarter.
• In the past five years, Buildings ranged from a high of $67.8 million in Q2 2015 to a low of $58.9 million in Q4 2013.
• Historically, Buildings has averaged $65.5 million across 3 years, with a median of $67.1 million in 2014.
• The sharpest annual moves came in 2014 and 2015: Buildings increased 15.05% in 2014, then grew 5.71% in 2015.
• A 3-year view of Buildings shows it stood at $58.9 million in 2013, then gained by 15.05% to $67.8 million in 2014, then increased by 0.09% to $67.8 million in 2015.
• The last three Buildings figures came in at $67.8 million (Q2 2015), $67.4 million (Q1 2015), and $67.8 million (Q4 2014), per Business Quant data.